• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HB&L系统在尿路感染快速诊断中的应用与评价

Application and evaluation of HB&L system in the rapid diagnosis of urinary tract infection.

作者信息

Huang Xianbin, Chang Zhenglin, Jiang Yueting, Chen Yuerong, Wu Haojie, Song Zhenfeng, Qi Defeng, Cheng Zhangkai Jason, Sun Baoqing

机构信息

Department of Clinical Laboratory, State Key Laboratory of Respiratory Disease, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

出版信息

Transl Androl Urol. 2025 Aug 30;14(8):2346-2357. doi: 10.21037/tau-2025-107. Epub 2025 Aug 26.

DOI:10.21037/tau-2025-107
PMID:40949448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12433155/
Abstract

BACKGROUND

Urinary tract infections (UTIs) are among the most prevalent bacterial infections worldwide, impacting millions annually. Traditional urine culture, the gold standard for UTI diagnosis, is associated with limitations such as lengthy culture times (24-48 hours), which can delay treatment. Additionally, the increasing prevalence of antibiotic resistance further emphasizes the need for rapid diagnostic methods to enhance clinical decision-making and reduce the unnecessary use of antibiotics. The HB&L system, developed by ALIFAX, presents a promising alternative that could potentially shorten diagnostic times, improving both treatment speed and patient outcomes. This study aims to evaluate the efficacy of the HB&L system for the rapid diagnosis of UTIs, comparing its performance with traditional urine culture methods, and to explore its feasibility and potential advantages in clinical practice.

METHODS

From June 2023 to February 2024, midstream urine samples were collected from 409 suspected UTI patients treated at The First Affiliated Hospital of Guangzhou Medical University. The samples were analyzed using both traditional urine culture methods and the HB&L system, with concurrent urinalysis results obtained from the same specimens. Traditional urine culture served as the reference standard to evaluate the diagnostic performance of the HB&L system and urinalysis for detecting UTIs. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated to assess the agreement between the methods. The Kappa coefficient was used for statistical analysis to determine the level of concordance.

RESULTS

The HB&L system demonstrated a sensitivity of 89.77%, specificity of 96.88%, PPV of 88.76%, NPV of 97.19%, and a Kappa coefficient of 0.86, indicating a high degree of concordance with traditional culture methods. In contrast, the Kappa coefficients for urinalysis parameters were 0.11 for protein, 0.08 for leukocyte esterase, and 0.44 for nitrite. The combined Kappa coefficient for these three infection-related urinalysis indicators was 0.11. The HB&L system provides results within 4.5 hours, whereas traditional methods typically require 24-48 hours. Overall, the diagnostic performance of urinalysis was inferior to that of the HB&L system.

CONCLUSIONS

The HB&L system has significant advantages in the rapid and accurate diagnosis of UTIs, making it a potential alternative or complement to traditional urine culture methods.

摘要

背景

尿路感染(UTIs)是全球最常见的细菌感染之一,每年影响数百万人。传统的尿液培养是UTI诊断的金标准,但存在诸如培养时间长(24 - 48小时)等局限性,这可能会延迟治疗。此外,抗生素耐药性的日益普遍进一步凸显了快速诊断方法对于加强临床决策和减少抗生素不必要使用的必要性。由ALIFAX开发的HB&L系统提供了一种有前景的替代方法,有可能缩短诊断时间,提高治疗速度并改善患者预后。本研究旨在评估HB&L系统对UTIs快速诊断的有效性,将其性能与传统尿液培养方法进行比较,并探讨其在临床实践中的可行性和潜在优势。

方法

2023年6月至2024年2月,从广州医科大学附属第一医院治疗的409例疑似UTI患者中收集中段尿样本。样本同时采用传统尿液培养方法和HB&L系统进行分析,并从相同标本中获得尿液分析结果。传统尿液培养作为评估HB&L系统和尿液分析检测UTIs诊断性能的参考标准。计算敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)以评估方法之间的一致性。使用Kappa系数进行统计分析以确定一致性水平。

结果

HB&L系统的敏感性为89.77%,特异性为96.88%,PPV为88.76%,NPV为97.19%,Kappa系数为0.86,表明与传统培养方法高度一致。相比之下,尿液分析参数的Kappa系数,蛋白质为0.11,白细胞酯酶为0.08,亚硝酸盐为0.44。这三个与感染相关的尿液分析指标的综合Kappa系数为0.11。HB&L系统在4.5小时内提供结果,而传统方法通常需要24 - 48小时。总体而言,尿液分析的诊断性能低于HB&L系统。

结论

HB&L系统在UTIs的快速准确诊断方面具有显著优势,使其成为传统尿液培养方法的潜在替代或补充方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf8/12433155/ec7a58b8ff3c/tau-14-08-2346-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf8/12433155/ec7a58b8ff3c/tau-14-08-2346-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf8/12433155/ec7a58b8ff3c/tau-14-08-2346-f1.jpg

相似文献

1
Application and evaluation of HB&L system in the rapid diagnosis of urinary tract infection.HB&L系统在尿路感染快速诊断中的应用与评价
Transl Androl Urol. 2025 Aug 30;14(8):2346-2357. doi: 10.21037/tau-2025-107. Epub 2025 Aug 26.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model.儿童尿路感染诊断与检查的临床有效性及成本效益:系统评价与经济模型
Health Technol Assess. 2006 Oct;10(36):iii-iv, xi-xiii, 1-154. doi: 10.3310/hta10360.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model.用于减少抗菌药物耐药性的尿路感染即时检测:一项系统评价和概念性经济模型
Health Technol Assess. 2024 Nov;28(77):1-109. doi: 10.3310/PTMV8524.
6
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Best methods for urine sample collection for diagnostic accuracy in women with urinary tract infection symptoms: a systematic review.最佳方法用于诊断女性尿路感染症状的尿液样本采集:系统评价。
Fam Pract. 2023 Feb 9;40(1):176-182. doi: 10.1093/fampra/cmac058.
9
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Rapid and accurate diagnosis of urinary tract infections using targeted next-generation sequencing: A multicenter comparative study with metagenomic sequencing and traditional culture methods.使用靶向新一代测序技术快速准确诊断尿路感染:一项与宏基因组测序和传统培养方法的多中心比较研究。
J Infect. 2025 Apr;90(4):106459. doi: 10.1016/j.jinf.2025.106459. Epub 2025 Mar 7.
2
Clinical biomarker profiles reveals gender differences and mortality factors in sepsis.临床生物标志物谱揭示了脓毒症中的性别差异和死亡因素。
Front Immunol. 2024 May 21;15:1413729. doi: 10.3389/fimmu.2024.1413729. eCollection 2024.
3
European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines.
欧洲泌尿外科学会泌尿感染指南:2024 年指南摘要。
Eur Urol. 2024 Jul;86(1):27-41. doi: 10.1016/j.eururo.2024.03.035. Epub 2024 May 6.
4
Urine Flow Cytometry and Dipstick Analysis in Diagnosing Bacteriuria and Urinary Tract Infections among Adults in the Emergency Department-A Diagnostic Accuracy Trial.急诊科成人尿流式细胞术和尿试纸分析在诊断菌尿症和尿路感染中的应用——一项诊断准确性试验
Diagnostics (Basel). 2024 Feb 13;14(4):412. doi: 10.3390/diagnostics14040412.
5
Assessment of UTI Diagnostic Techniques Using the Fuzzy-PROMETHEE Model.使用模糊偏好顺序结构评估尿路感染诊断技术
Diagnostics (Basel). 2023 Nov 10;13(22):3421. doi: 10.3390/diagnostics13223421.
6
Urinary Tract Infections: Prevention, Diagnosis, and Treatment.尿路感染:预防、诊断与治疗
J Clin Med. 2023 Aug 1;12(15):5058. doi: 10.3390/jcm12155058.
7
The genetic associations of COVID-19 on genitourinary symptoms.COVID-19 对泌尿生殖系统症状的遗传相关性。
Front Immunol. 2023 Jun 21;14:1216211. doi: 10.3389/fimmu.2023.1216211. eCollection 2023.
8
Unmet needs in uncomplicated urinary tract infection in the United States and Germany: a physician survey.美国和德国单纯性尿路感染未满足的需求:一项医生调查。
BMC Infect Dis. 2023 May 3;23(1):281. doi: 10.1186/s12879-023-08207-x.
9
Evaluation of an automated rapid urine culture method for urinary tract infection: Comparison with gold standard conventional culture method.用于尿路感染的自动化快速尿液培养方法的评估:与金标准传统培养方法的比较。
Indian J Med Microbiol. 2023 Mar-Apr;42:19-24. doi: 10.1016/j.ijmmb.2023.01.003. Epub 2023 Jan 20.
10
Optimizing antimicrobial therapy in urinary tract infections: A focus on urine culture and sensitivity testing.优化尿路感染的抗菌治疗:聚焦尿培养与药敏试验
Front Pharmacol. 2022 Nov 30;13:1058669. doi: 10.3389/fphar.2022.1058669. eCollection 2022.